What Donna Reed's Story Can Help Us Understand About Pancreatic Cancer

What the 1986 report said

United Press International reported on 15 January 1986 that Donna Reed had died at her home the previous day, aged 64.

The report gave the sequence: she had been in Cedars-Sinai Medical Center being treated for a bleeding ulcer, and while she was there, in December, she was found to have pancreatic cancer. She left the hospital three days before she died. Her husband, retired Army Colonel Grover Asmus, was with her.

That is the record. It is thin by modern standards, and this page does not fill the gaps in.

One detail in it is still instructive. She was not sent for a scan because of a pancreatic symptom. The cancer turned up during care for something else, weeks before she died.

What has and has not changed since 1986

Forty years on, the tools are unrecognizable. Helical CT, MRI, and endoscopic ultrasound, all standard in NCI's diagnostic pathway now, either did not exist or were not in routine use then.

The outcome has moved much less than the technology.

SEER, the federal cancer surveillance program, put five-year relative survival for pancreatic cancer at about 3% for people diagnosed in the mid-1970s. For people diagnosed from 2016 through 2022 it is 13.7%. Real progress, and still the lowest figure among major cancers.

What has barely moved is when it is found. Only 15% of cases are caught while confined to the pancreas.

Why the pancreas hides a tumor

NCI's clinical summary explains the difficulty in three parts. Early pancreatic cancer produces few noticeable symptoms. The symptoms it does produce look like pancreatitis or an ulcer. And the gland itself is tucked behind other organs, which makes it hard to see clearly on imaging.

Reed's story sits inside that second point. Upper abdominal pain being treated as an ulcer is exactly the overlap NCI describes.

This does not mean her care was wrong. It means the disease is genuinely hard to catch, which is why NCI still does not recommend screening for people at average risk.

What the pancreas does

The gland is about six inches long and lies behind the stomach.

Exocrine cells produce the juices that digest food. Endocrine cells, including islet cells, make hormones including insulin. Cancers of these two cell populations are different diseases with different outlooks, and NCI treats them in separate summaries. Most pancreatic cancer is the exocrine type. Our overview of pancreatic cancer sets out the difference.

When to get checked

NCI says early pancreatic cancer may cause nothing at all. As it grows, symptoms may include jaundice, which is yellowing of the skin and the whites of the eyes; light-colored stools; dark urine; pain in the upper or middle abdomen and back; unexplained weight loss; loss of appetite; and fatigue.

Three practical thresholds are worth carrying.

Yellowing of the eyes or skin with no pain and no fever needs assessment within days. It is one of the few early signals this cancer gives.

Upper abdominal pain that bores through to the back, especially with appetite or weight loss, deserves an appointment rather than another course of acid suppression. If reflux or ulcer treatment is not working after a few weeks, say so, and ask what else is being considered.

New diabetes after age 50 with no clear cause, particularly with weight loss, is worth mentioning. NCI lists a personal history of diabetes among pancreatic cancer risk factors.

NCI also lists smoking, excess body weight, chronic pancreatitis, a family history of pancreatic cancer or pancreatitis, and several inherited syndromes. It adds that many people with risk factors never develop the disease, and some people with none do.

What treatment involves now

Removing the tumor is the only route to cure. NCI describes the Whipple procedure, which takes the head of the pancreas along with the gallbladder, part of the stomach, part of the small intestine, and the bile duct; total pancreatectomy; and distal pancreatectomy for tumors in the body and tail.

Chemotherapy does most of the rest. Modified FOLFIRINOX, a four-drug regimen, and gemcitabine-based regimens are both in use, given before surgery in some situations and after it in others.

NCI's clinical summary is blunt about who benefits from an operation: people with unresectable, metastatic, or recurrent disease are unlikely to. It also states that any stage of pancreatic cancer is a reasonable setting for a clinical trial, given how limited conventional treatment remains.

Symptom relief runs alongside all of it. NCI lists unblocking the bile duct, relieving stomach outlet obstruction, pain control, and psychological care as measures that can improve quality of life without necessarily extending it.

The numbers, and their reach

SEER publishes an American Cancer Society estimate of about 67,530 new pancreatic cancer diagnoses and 52,740 deaths in the United States in 2026. The median age at diagnosis is 71.

Five-year relative survival is 43.6% for localized disease, 17.0% for regional, and 3.4% for distant.

Reed was 64 and, by the timeline in the UPI report, was diagnosed about a month before she died. Nothing in that pattern tells anyone what to expect. Registry averages describe tens of thousands of people at once, and no individual is an average. Our page on cancer statistics covers how to read them without reading too much in.

What to keep in perspective

A death in 1986 says almost nothing about a diagnosis in 2026. Imaging, surgery, and chemotherapy have all changed, and the survival figure has roughly quadrupled.

It also says nothing about any individual. Reed's course was hers.

What the story does carry forward is the mechanism: this cancer is usually found late, often by accident, and the practical response is not fear but persistence. If a stomach complaint is not settling on treatment, that is a reason to ask what else it could be.

Sources

• UPI Archives: Actress Donna Reed dead at 64
• NCI PDQ: Pancreatic Cancer Treatment (Health Professional Version)
• NCI PDQ: Pancreatic Cancer Treatment (Patient Version)
• NCI SEER Cancer Stat Facts: Pancreatic Cancer

How this article was prepared

An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.

See an error, old source, or unclear wording? Tell us.